Our attorneys are pursuing claims against Pfizer for injuries caused by Oxbryta.  Oxbyta is a medication for sickle cell disease that was supposed to help patients with the side effects caused by their sickle cell disease.  The drug was granted accelerated approval in 2019.  However in September 2024, Pfizer voluntarily withdrew Oxbryta from the market following serious safety concerns.  The FDA has advised healthcare professionals to stop prescribing the drug.

Sickle cell disease is a blood disorder that people inherit from their parents.  It affects hemoglobin, the protein in red blood cells that carries oxygen throughout the body.  In people with sickle cell, hemoglobin is abnormal, which causes the red blood cels to become stiff and shaped like a sickle or crescent. These sickle-shaped cells can block blood flow, which can lead to anemia, pain, infections, and other serous health problems.  Oxbrtya was designed to help red blood cells stay flexible, which was supposed to reduce anemia and other problems which sickle cell patients experience.  However, the risks of this drug outweigh its benefits. 

Our attorneys are investigating cases where patients suffered Oxbryta vaso-occlusive crises (VOC) and injuries occurring resulting from vaso-occlusive crises and death.  A vaso-occlusive crisis happens when sickled red blood cells block blood flow, cutting off oxygen to tissues.  When the body tries to solve the problem, it begins inflammation, leading to severe pain.  VOC pain can occur anywhere but is most common in the back, chest, or arms or legs.

Please contact us if you have experienced a vaso-occlusive crises while taking Oxbryta.  We are here to fight for your rights and seek the compensation you deserve.